Literature DB >> 15186532

Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya.

Chunfu Yang1, Ming Li, Ya-Ping Shi, Jorn Winter, Anna M van Eijk, John Ayisi, Dale J Hu, Richard Steketee, Bernard L Nahlen, Renu B Lal.   

Abstract

The high genetic diversity of HIV-1 continues to complicate effective vaccine development. To better understand the extent of genetic diversity, intersubtype recombinants and their relative contribution to the HIV epidemic in Kenya, we undertook a detailed molecular epidemiological investigation on HIV-1-infected women attending an antenatal clinic in Kisumu, Kenya. Analysis of gag-p24 region from 460 specimens indicated that 310 (67.4%) were A, 94 (20.4%) were D, 28 (6.1%) were C, 9 (2.0%) were A2, 8 (1.7%) were G, and 11 (2.4%) were unclassifiable. Analysis of the env -gp41 region revealed that 326 (70.9%) were A, 85 (18.5%) D, 26 (5.7%) C, 9 (2.0%) each of A2 and G, 4(0.9%) unclassifiable, and 1 (0.2%) CRF02_AG. Parallel analyses of the gag-p24 and env-gp41 regions indicated that 344 (74.8%) were concordant subtypes, while the remaining 116 (25.2%) were discordant subtypes. The most common discordant subtypes were D/A (40, 8.7%), A/D (27, 5.9%), C/A (11, 2.4%), and A/C (8, 1.7%). Further analysis of a 2.1-kb fragment spanning the gag-pol region from 38 selected specimens revealed that 19 were intersubtype recombinants and majority of them were unique recombinant forms. Distribution of concordant and discordant subtypes remained fairly stable over the 4-year period (1996-2000) studied. Comparison of amino acid sequences of gag-p24 and env-gp41 regions with the subtype A consensus sequence or Kenyan candidate vaccine antigen (HIVA) revealed minor variations in the immunodominant epitopes. These data provide further evidence of high genetic diversity, with subtype A as the predominant subtype and a high proportion of intersubtype recombinants in Kenya.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186532     DOI: 10.1089/088922204323087822

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  HIV diversity, molecular epidemiology, and the role of recombination.

Authors:  Gustavo H Kijak; Francine E McCutchan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

2.  Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.

Authors:  Antoine Chaillon; Gabriel A Wagner; N Lance Hepler; Susan J Little; Sergei L Kosakovsky Pond; Gemma Caballero; Mary E Pacold; Pham Phung; Terri Wrin; Douglas D Richman; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

3.  Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.

Authors:  Diane L Hirigoyen; Charles P Cartwright
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Complex Subtype Diversity of HIV-1 Among Drug Users in Major Kenyan Cities.

Authors:  Kamini Gounder; Micah Oyaro; Nagavelli Padayachi; Thando Mbali Zulu; Tulio de Oliveira; John Wylie; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-01       Impact factor: 2.205

5.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

6.  Evidence of a novel RNA secondary structure in the coding region of HIV-1 pol gene.

Authors:  Qi Wang; Ian Barr; Feng Guo; Christopher Lee
Journal:  RNA       Date:  2008-10-30       Impact factor: 4.942

7.  HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.

Authors:  Clement Zeh; Paul J Weidle; Lillian Nafisa; Humphrey M Lwamba; Jully Okonji; Emily Anyango; Philip Bondo; Rose Masaba; Mary Glenn Fowler; John N Nkengasong; Michael C Thigpen; Timothy Thomas
Journal:  PLoS Med       Date:  2011-03-29       Impact factor: 11.069

8.  HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.

Authors:  Rami Kantor; Allison DeLong; Maya Balamane; Leeann Schreier; Robert M Lloyd; Wilfred Injera; Lydia Kamle; Fidelis Mambo; Sarah Muyonga; David Katzenstein; Joseph Hogan; Nathan Buziba; Lameck Diero
Journal:  J Int AIDS Soc       Date:  2014-11-18       Impact factor: 5.396

9.  Phylodynamics of HIV-1 subtype C epidemic in east Africa.

Authors:  Edson Oliveira Delatorre; Gonzalo Bello
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey.

Authors:  Andrea A Kim; Bharat S Parekh; Mamo Umuro; Tura Galgalo; Rebecca Bunnell; Ernest Makokha; Trudy Dobbs; Patrick Murithi; Nicholas Muraguri; Kevin M De Cock; Jonathan Mermin
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.